Trial intelligence / Profile preview

SHAPE Validation with Sonazoid

NCT03245255Phase 2Completed

Sponsor
Thomas Jefferson University
Start
Dec 2017
Primary completion
Sep 2020
Modality
Nanoparticles
Countries
1
01

Overview

A Phase 2 trial of sonazoid, sponsored by Thomas Jefferson University. Started Dec 2017; status: completed.

02

Drugs

sonazoid

Beyond the preview

Go deeper on NCT03245255.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03245255.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call